Skip to content

Clinical trials

Phase 3 Carcinoma, Ovarian Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 3 Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20023
20032
20044
20052
20063
20071
20093
20113
20122
20131
20162
20174
20183
20194
20204
20214
20223
20232
20241
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Unknown status15
Recruiting10
Terminated8
Active, not recruiting5
Not yet recruiting5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group6
Medical Research Council6
AGO Study Group4
AstraZeneca4
European Organisation for Research and Treatment of Cancer - EORTC4
Fred Hutchinson Cancer Center3
pharmaand GmbH3
ImmunoGen, Inc.2
Japanese Gynecologic Oncology Group2
Lei Li2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial89
Ovarian Neoplasms55
Fallopian Tube Neoplasms43
Neoplasms12
Breast Neoplasms11
Testicular Neoplasms10
Blast Crisis9
Burkitt Lymphoma9
Leukemia, Lymphocytic, Chronic, B-Cell9
Leukemia, Myeloid, Accelerated Phase9

Trials

Showing 76 to 89 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.